Spinal fluid test flagged MS cases another test missed
By MS Buddy ·
Summarized from Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, Nov 2026 · PubMed. AI-generated summary. Not medical advice.
Observational study · 140 people with and without MS who had spinal fluid testing
Research by Milovan Roganovic, Slavisa Perunicic and 7 colleagues at Clinic for Neurology and Clinical Center of Montenegro in Montenegro.
Can a spinal fluid test flag MS when the standard test is negative?
Key Takeaway
A spinal fluid test that measures signs of immune activity was better than the standard test at telling MS apart from other conditions.

What They Found
The test that gives a number showed higher results in people with MS than in people with other conditions. At a cutoff of about 9, it correctly flagged about 89% of people with MS. It also correctly gave a negative result for about 96% of people without MS. The two spinal fluid tests agreed for 122 of 140 people. Among 16 people who tested negative on the standard test but above the new cutoff, 13 were diagnosed with MS.
Who Should Care and Why
The study included people with and without MS who had spinal fluid collected during routine testing for nervous system conditions. Of those, 64 were diagnosed with MS. The other 76 were diagnosed with other nervous system conditions. The comparison is relevant to people being tested for MS because it shows how often the two tests agreed. It also shows that some people diagnosed with MS tested negative on the standard test.
Important Considerations
Researchers looked back at records for 140 people at one center. The cutoff was chosen using results from that center, so it still needs to be checked in other groups. The findings do not show that either spinal fluid test can diagnose MS on its own.
AI-generated summary — for informational purposes only, not medical advice
Read the original abstract
Published in Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia by et al.. Reproduced from the PubMed record.
The kappa free light chain (KFLC) index has emerged as a quantitative marker of intrathecal immunoglobulin synthesis and is increasingly used in the diagnostic evaluation of multiple sclerosis (MS). However, the optimal diagnostic threshold remains uncertain and may vary across clinical populations. We aimed to evaluate the diagnostic performance of the KFLC index in a real-world neurological cohort, compare it with oligoclonal bands (OCBs), and determine a locally optimal cut-off value. We conducted a retrospective, single-center study including 140 patients who underwent lumbar puncture during routine neurological diagnostic work-up. Sixty-four patients were diagnosed with MS and 76 with other neurological disorders. Demographic and cerebrospinal fluid parameters, including OCB status and KFLC index, were analyzed. Diagnostic performance was assessed using receiver operating characteristic (ROC) analysis, and the optimal KFLC cut-off was determined using Youden's index alongside the established 6.1 consensus cut-off, with 9.3 selected to maximize diagnostic specificity. Agreement between dichotomized KFLC results and OCB status was evaluated using Cohen's kappa. The KFLC index was significantly higher in patients with MS than in non-MS patients [median 43.4 (IQR 16.6-88.1) vs. 1.8 (IQR 1.4-2.8), p<0.001]. ROC analysis showed high diagnostic accuracy for the KFLC index, with an AUC of 0.954 (95% CI 0.919-0.990), compared with 0.831 (95% CI 0.756-0.905) for OCB status. A locally optimal KFLC index cut-off of 9.3 yielded 89.1% sensitivity, 96.0% specificity, a positive predictive value of 95.0%, a negative predictive value of 91.3%, and an overall accuracy of 92.9%. OCB positivity was observed in 68.8% of MS patients and 2.6% of non-MS patients. KFLC and OCB results were concordant in 122 of 140 patients (87.1%), with substantial agreement (Cohen's κ=0.73). Among 16 OCB-negative patients with KFLC index values above the selected threshold, 13 were ultimately diagnosed with MS. The KFLC index showed high diagnostic accuracy for MS in a heterogeneous real-world neurological cohort. The locally derived cut-off of 9.3 provided a favorable balance between sensitivity and specificity and identified a clinically relevant subgroup of OCB-negative patients with MS. These findings support further evaluation of the study-derived threshold in independent cohorts and contextual interpretation of KFLC and OCB within the overall diagnostic assessment.
Categories
Explore more research
Related MS research

11/20/2026
In people with MS, brain scan readings were stronger when images lined up with the scanner’s magneti
Read More
11/20/2026
A study of 59 people with relapsing-remitting MS found a computer tool helped doctors read brain sca
Read More
11/19/2026
A Japanese hospital study linked MS to about 9% of first eye nerve inflammation cases. Other immune
Read More
11/18/2026
An adjusted MRI scan found more veins within MS brain lesions in 17 people with MS. It improved scan
Read More
1/1/2026
After a car crash, brain and spine scans revealed signs of MS in an 18-year-old male. Further tests
Read More
11/14/2026
An opinion paper explains why MS brain scans can show tissue loss without proving nerve signal failu
Read MoreNot all studies carry the same weight: sample size, study design and whether results were replicated all matter. The credibility score above reflects the journal, and the original paper is linked under More Details. Read how MS Buddy selects and scores research, and talk to your MS care team before acting on any study.
